惊恐导致杏仁核独特的分子与网络改变从而促进恐惧反应
该研究探讨惊恐易感状态如何导致持续性恐惧。研究发现,光遗传学激活PeF至BLA的谷氨酸能终端可增强恐惧获得、延迟消退并诱导恐惧反应持续3周;惊恐易感大鼠BLA主神经元抑制性传递改变、兴奋性传递增强,mGluR2蛋白水平降低;mGluR2正向变构调节剂可阻断乳酸钠诱导的惊恐反应并纠正恐惧消退缺陷,在部分共病惊恐障碍患者中实现惊恐症状完全缓解。
要点
- PeF至BLA谷氨酸能通路激活可增强恐惧获得并延迟消退
- 惊恐易感大鼠BLA中mGluR2蛋白水平降低且突触传递失衡
- mGluR2正向变构调节剂可阻断惊恐反应并改善恐惧消退
核心结论
- 惊恐易感状态导致杏仁核网络内mGluR2功能特异性降低并促进恐惧。
- mGluR2正向变构调节剂可能是惊恐障碍和创伤后应激障碍患者惊恐症状的靶向治疗。
研究设计与样本
- 研究采用光遗传学激活PeF至BLA谷氨酸能终端,并利用惊恐易感大鼠模型进行机制探讨。
- 在部分共病惊恐障碍患者中观察了mGluR2正向变构调节剂的治疗效果。
主要发现
- 光遗传学激活PeF至BLA谷氨酸能终端增强恐惧获得、延迟消退并诱导恐惧反应持续3周。
- 惊恐易感大鼠表现出延迟消退,BLA主神经元抑制性突触传递改变、兴奋性突触传递增强,mGluR2蛋白水平降低。
- mGluR2正向变构调节剂降低惊恐易感大鼠BLA切片中的谷氨酸神经传递。
- mGluR2正向变构调节剂阻断乳酸钠诱导的惊恐反应并纠正恐惧消退缺陷。
- 在部分共病惊恐障碍患者中,mGluR2正向变构调节剂治疗使惊恐症状完全缓解。
临床怎么用
- mGluR2正向变构调节剂可能作为惊恐障碍和创伤后应激障碍患者惊恐症状的靶向治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recurrent panic attacks (PAs) are a common feature of panic disorder (PD) and post-traumatic stress disorder (PTSD). Several distinct brain regions are involved in the regulation of panic responses, such as perifornical hypothalamus (PeF), periaqueductal gray, amygdala and frontal cortex. We have previously shown that inhibition of GABA synthesis in the PeF produces panic-vulnerable rats. Here, we investigate the mechanisms by which a panic-vulnerable state could lead to persistent fear. We first show that optogenetic activation of glutamatergic terminals from the PeF to the basolateral amygdala (BLA) enhanced the acquisition, delayed the extinction and induced the persistence of fear responses 3 weeks later, confirming a functional PeF-amygdala pathway involved in fear learning. Similar to optogenetic activation of PeF, panic-prone rats also exhibited delayed extinction. Next, we demonstrate that panic-prone rats had altered inhibitory and enhanced excitatory synaptic transmission of the principal neurons, and reduced protein levels of metabotropic glutamate type 2 receptor (mGluR2) in the BLA. Application of an mGluR2-positive allosteric modulator (PAM) reduced glutamate neurotransmission in the BLA slices from panic-prone rats. Treating panic-prone rats with mGluR2 PAM blocked sodium lactate (NaLac)-induced panic responses and normalized fear extinction deficits. Finally, in a subset of patients with comorbid PD, treatment with mGluR2 PAM resulted in complete remission of panic symptoms. These data demonstrate that a panic-prone state leads to specific reduction in mGluR2 function within the amygdala network and facilitates fear, and mGluR2 PAMs could be a targeted treatment for panic symptoms in PD and PTSD patients.
引用
- Molosh AI, Dustrude ET, Lukkes JL, et al. Panic results in unique molecular and network changes in the amygdala that facilitate fear responses. Mol Psychiatry. 2018. PMID: 30108314. doi:10.1038/s41380-018-0119-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。